Combalgin® (Gel) Instructions for Use
Marketing Authorization Holder
Promomed Rus LLC (Russia)
Manufactured By
Biokhimik, JSC (Russia)
ATC Code
M02AA13 (Ibuprofen)
Active Substance
Ibuprofen (Rec.INN registered by WHO)
Dosage Form
| Combalgin® | Gel for external use 5%: tubes 25 g, 30 g, 50 g, 60 g, 100 g, 120 g, 150 g, 180 g, or 200 g 1 or 2 pcs.; 20 g, 35 g, 40 g, 70 g, 80 g, 125 g, 130 g, 135 g, 140 g, or 145 g 1 pc. |
Dosage Form, Packaging, and Composition
Gel for external use transparent or slightly opalescent, colorless, homogeneous, with a characteristic odor.
| 100 g | |
| Ibuprofen | 5 g |
Excipients : isopropanol – 5 g, hydroxyethylcellulose – 1.8 g, sodium hydroxide – 1 g, benzyl alcohol – 1 g, purified water – 86.2 g.
20 g – aluminum tubes (1) – cardboard packs.
25 g – aluminum tubes (1) – cardboard packs.
25 g – aluminum tubes (2) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (2) – cardboard packs.
35 g – aluminum tubes (1) – cardboard packs.
40 g – aluminum tubes (1) – cardboard packs.
50 g – aluminum tubes (1) – cardboard packs.
50 g – aluminum tubes (2) – cardboard packs.
60 g – aluminum tubes (1) – cardboard packs.
60 g – aluminum tubes (2) – cardboard packs.
70 g – aluminum tubes (1) – cardboard packs.
80 g – aluminum tubes (1) – cardboard packs.
100 g – aluminum tubes (1) – cardboard packs.
100 g – aluminum tubes (2) – cardboard packs.
120 g – aluminum tubes (1) – cardboard packs.
120 g – aluminum tubes (2) – cardboard packs.
125 g – aluminum tubes (1) – cardboard packs.
130 g – aluminum tubes (1) – cardboard packs.
135 g – aluminum tubes (1) – cardboard packs.
140 g – aluminum tubes (1) – cardboard packs.
145 g – aluminum tubes (1) – cardboard packs.
150 g – aluminum tubes (1) – cardboard packs.
150 g – aluminum tubes (2) – cardboard packs.
180 g – aluminum tubes (1) – cardboard packs.
180 g – aluminum tubes (2) – cardboard packs.
200 g – aluminum tubes (1) – cardboard packs.
200 g – aluminum tubes (2) – cardboard packs.
Clinical-Pharmacological Group
NSAIDs for external use
Pharmacotherapeutic Group
Drugs for external use for muscle and joint pain; non-steroidal anti-inflammatory drugs for external use
Pharmacological Action
NSAID, a derivative of phenylpropionic acid. When applied externally, it has an anti-inflammatory and analgesic effect. Reduces morning stiffness, helps increase the range of motion in the joints.
The mechanism of action is associated with the inhibition of COX activity, the main enzyme in the metabolism of arachidonic acid, which is a precursor of prostaglandins that play a major role in the pathogenesis of inflammation, pain, and fever. The analgesic effect is due to both a peripheral mechanism (indirectly, through the suppression of prostaglandin synthesis) and a central mechanism (by inhibiting the synthesis of prostaglandins in the central and peripheral nervous system).
Pharmacokinetics
After application to the skin, Ibuprofen is detected in the epidermis and dermis after 24 hours. It reaches a high therapeutic concentration in the underlying soft tissues, joints, and synovial fluid. Clinically significant systemic absorption practically does not occur. The Cmax of ibuprofen in blood plasma with external use is 5% of the Cmax level with oral administration of ibuprofen.
80% of the dose is excreted in the urine, mainly in the form of metabolites (70%), 10% – unchanged; 20% is excreted through the intestines in the form of metabolites.
Indications
As an analgesic and anti-inflammatory agent for conditions such as muscle pain, back pain, arthritis, pain from ligament injuries and sprains, sports injuries, neuralgia.
ICD codes
| ICD-10 code | Indication |
| M05 | Seropositive rheumatoid arthritis |
| M13.9 | Arthritis, unspecified |
| M15 | Polyosteoarthritis |
| M19.9 | Unspecified arthrosis |
| M25.5 | Pain in joint |
| M42 | Spinal osteochondrosis |
| M45 | Ankylosing spondylitis |
| M47 | Spondylosis |
| M54 | Dorsalgia |
| M54.1 | Radiculopathy |
| M54.3 | Sciatica |
| M54.4 | Lumbago with sciatica |
| M65 | Synovitis and tenosynovitis |
| M70 | Soft tissue disorders related to use, overuse, and pressure |
| M71 | Other bursopathies |
| M79.1 | Myalgia |
| M79.2 | Neuralgia and neuritis, unspecified |
| T14.3 | Dislocation, sprain and strain of joint and ligament of unspecified body region |
| ICD-11 code | Indication |
| 8B93.Z | Radiculopathy, unspecified |
| 8E4A.1 | Paraneoplastic or autoimmune diseases of the peripheral or autonomic nervous system |
| FA05 | Polyosteoarthritis |
| FA0Z | Osteoarthritis, unspecified |
| FA20.0 | Seropositive rheumatoid arthritis |
| FA2Z | Inflammatory arthropathies, unspecified |
| FA85.Z | Defects of vertebral end-plates, unspecified |
| FA8Z | Degenerative disease of spine, unspecified |
| FA92.0Z | Ankylosing spondylitis, unspecified |
| FB40.Z | Tenosynovitis, unspecified |
| FB50.1 | Bursitis associated with use, overuse or pressure |
| FB50.Z | Bursitis, unspecified |
| FB56 | Specified soft tissue diseases, not elsewhere classified |
| FB56.2 | Myalgia |
| ME82 | Pain in joint |
| ME84.20 | Lumbago with sciatica |
| ME84.3 | Sciatica |
| ME84.Z | Back pain, unspecified |
| ND56.3 | Dislocation, sprain or strain of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply the gel externally to the affected area of skin.
Use a strip of gel 4 to 10 cm long, depending on the size of the area being treated.
Apply and rub in gently until fully absorbed.
Use the gel 2 to 3 times per day.
Maintain an interval of at least 4 hours between applications.
Do not exceed the maximum daily application area; treat no more than 15-20% of the body surface.
The maximum duration of continuous use is 14 days for self-medication.
Discontinue use and consult a physician if symptoms persist or worsen after 2-3 days of treatment.
Avoid contact with eyes, mucous membranes, and open wounds.
Do not apply to skin with broken integrity, including infected abrasions or eczema.
Wash hands thoroughly with soap and water after each application, unless the hands are the treatment area.
Do not use with an occlusive dressing.
Avoid exposing the treated area to direct sunlight or UV lamps.
Adverse Reactions
Local reactions with external use may include skin hyperemia, a sensation of burning or tingling.
Contraindications
Hypersensitivity to ibuprofen; “aspirin triad” (including in history); impaired skin integrity at the application site (including infected wounds and abrasions, weeping dermatitis, eczema); children under 14 years of age; pregnancy, lactation period.
With caution
In the presence of concomitant diseases of the liver and kidneys, gastrointestinal tract, exacerbation of hepatic porphyria, with bronchial asthma, urticaria, rhinitis, polyps of the nasal mucosa, chronic heart failure, as well as in elderly patients.
Use in Pregnancy and Lactation
Use during pregnancy and breastfeeding is contraindicated.
Use in Hepatic Impairment
Contraindicated in severe liver dysfunction. Use with caution in concomitant liver diseases.
Use in Renal Impairment
Contraindicated in severe renal dysfunction. Use with caution in concomitant kidney diseases.
Pediatric Use
Ibuprofen is contraindicated for external use in children under 14 years of age.
Geriatric Use
Use with caution in elderly patients.
Special Precautions
When applying externally, avoid contact with eyes and lips.
Do not use under an occlusive (airtight) dressing.
Avoid sunlight on the application area.
Drug Interactions
Theoretically, with simultaneous use with other NSAIDs, an increase in side effects is possible.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer